A phase II trial of acridinyl anisidine (m-AMSA) and VP-16-213 in refractory acute myeloid leukemia in adults
Article
Overview
publication date
- December 1, 1982
published in
Identity
Scopus Document Identifier
- 0020421880
Additional Document Info
volume
- Vol. 1